Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Mei Pharma Inc (NQ: MEIP ) 3.380 -0.020 (-0.59%) Streaming Delayed Price Updated: 11:09 AM EDT, Aug 14, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Mei Pharma Inc < Previous 1 2 3 4 5 6 7 Next > Earnings Outlook For MEI Pharma September 25, 2023 Via Benzinga MEI Pharma to Report 2023 Fiscal Year End Financial Results and Provide Corporate Overview on September 26, 2023 September 21, 2023 From MEI Pharma, Inc. Via Business Wire MEI Pharma Confirms Receipt of Director Nominations From Anson and Cable Car September 18, 2023 From MEI Pharma, Inc. Via Business Wire MEI Pharma Announces First Patient Dosed in Clinical Study Evaluating ME-344 Plus Bevacizumab (AVASTIN®) in Patients with Previously Treated Metastatic Colorectal Cancer August 16, 2023 From MEI Pharma, Inc. Via Business Wire MEI Pharma Announces Results of Special Meeting of Stockholders July 23, 2023 From MEI Pharma, Inc. Via Business Wire MEI Pharma Reminds Shareholders to Vote Today FOR the Infinity Transaction July 19, 2023 From MEI Pharma, Inc. Via Business Wire MEI Pharma Responds to Anson and Cable Car July 18, 2023 From MEI Pharma, Inc. Via Business Wire Anson and Cable Car File Preliminary Consent Materials to Remove Entire Board of Directors at MEI Pharma, Inc. July 17, 2023 From Anson Funds Management LP Via GlobeNewswire MEI Pharma Encourages Shareholders to Vote FOR the Infinity Transaction July 17, 2023 From MEI Pharma, Inc. Via Business Wire MEI Pharma Postpones Special Meeting of Shareholders July 13, 2023 From MEI Pharma, Inc. Via Business Wire MEI Pharma Provides Final Reminder to Shareholders to Vote Today FOR the Merger With Infinity Pharmaceuticals July 11, 2023 From MEI Pharma, Inc. Via Business Wire Infinity Pharmaceuticals Says Second Proxy Advisory Firm Recommends Shareholders To Approve Proposed Merger July 10, 2023 Infinity Pharmaceuticals Inc (NASDAQ: INFI) announced further design features of its Phase 2 MARIO-8 study in Squamous Cell Cancer of the Via Benzinga MEI Pharma Reminds Shareholders to Vote FOR the Merger with Infinity Pharmaceuticals July 07, 2023 From MEI Pharma, Inc. Via Business Wire MEI Pharma Highlights Recommendation by Leading Independent Proxy Advisory Firm ISS to Vote “FOR” Pending Transaction with Infinity Pharmaceuticals July 05, 2023 From MEI Pharma, Inc. Via Business Wire MEI Pharma Mails Letter to Shareholders Reiterating Value Creating Potential of Proposed Transaction with Infinity Pharmaceuticals June 29, 2023 From MEI Pharma, Inc. Via Business Wire MEI Pharma Responds to Anson and Cable Car June 27, 2023 From MEI Pharma, Inc. Via Business Wire Anson Funds and Cable Car Capital Issue Statement Regarding the Inferior Proposed Transaction between MEI Pharma and Infinity Pharmaceuticals June 27, 2023 From Anson Funds Management LP Via GlobeNewswire MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates June 15, 2023 From Infinity Pharmaceuticals, Inc. Via Business Wire MEI Pharma Announces Planned Departure of Chief Financial Officer Brian Drazba and Appointment of Justin File as Successor June 13, 2023 From MEI Pharma, Inc. Via Business Wire MEI Pharma Announces Planned Departure of CEO Daniel P. Gold, Ph.D. and Appointment of David M. Urso as Successor June 02, 2023 From MEI Pharma, Inc. Via Business Wire Anson Funds and Cable Car Capital Issue Statement Regarding MEI Pharma’s Rejection of Their Acquisition Proposal June 01, 2023 From Anson Funds Management LP Via GlobeNewswire MEI Pharma Board of Directors Rejects Unsolicited Proposal June 01, 2023 From MEI Pharma, Inc. Via Business Wire MEI Pharma Confirms Receipt of Unsolicited Acquisition Proposal May 30, 2023 From MEI Pharma, Inc. Via Business Wire Clinical Triumph: MEI Pharma's Voruciclib Demonstrates Encouraging Activity in AML Patients May 23, 2023 MEI Pharma Inc (NASDAQ: MEIP) announced an update to the Phase 1 study of voruciclib, an orally administered cyclin-dependent kinase 9 inhibitor, in patients with relapsed and refractory (R/R) acute... Via Benzinga MEI Pharma Announces Update of Ongoing Phase 1 Study Evaluating Oral CDK9 Inhibitor Voruciclib Alone and in Combination with Venetoclax in Patients with Acute Myeloid Leukemia or B-Cell Malignancies May 23, 2023 From MEI Pharma, Inc. Via Business Wire MEI Pharma Reports Third Quarter Fiscal Year 2023 Results and Operational Highlights May 11, 2023 From MEI Pharma, Inc. Via Business Wire 10 Short Squeeze Stocks To Watch: Getty Images, Guardforce AI And 2 Stocks Moving Up Over 1,000 Positions On The Leaderboard April 24, 2023 Potential short squeeze plays gained steam in 2021, continued through 2022, and remain a focus of new traders looking for the next huge move. High short interest and high cost to borrow are among the... Via Benzinga Here's Why MEI Pharma (MEIP) Stock Is Moving April 17, 2023 MEI Pharma (NASDAQ: MEIP) shares are trading lower by roughly 2.54% to $4.68 Monday morning, though rebounding off the session low of $4.30, after the company announced and effected a 1-for-20 reverse... Via Benzinga MEI Pharma Announces 1-for-20 Reverse Stock Split April 14, 2023 From MEI Pharma, Inc. Via Business Wire MEI Pharma And 2 Other Penny Stocks Insiders Are Aggressively Buying March 02, 2023 The Dow Jones closed slightly higher on first trading day of March. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.